NCT07347132 Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor Status COMPLETED Phase NA
NCT07252297 The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT07206225 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer Status RECRUITING Phase PHASE1
NCT07144319 Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy Status RECRUITING Phase N/A
NCT06990061 Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study Status NOT_YET_RECRUITING Phase NA
NCT06929286 A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) Status RECRUITING Phase PHASE3
NCT06816017 A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC) Status WITHDRAWN Phase PHASE1
NCT06781879 Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE4
NCT06637423 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) Status RECRUITING Phase PHASE1/PHASE2
NCT06632964 A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE1
NCT06503614 A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer Status RECRUITING Phase PHASE2
NCT06443944 An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG Status AVAILABLE Phase N/A
NCT06253845 Study of CG0070 After Transurethral Resection in Patients With IR NMIBC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06245603 A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer Status RECRUITING Phase NA
NCT06241755 Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) Status RECRUITING Phase PHASE3
NCT06235853 Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer Status COMPLETED Phase N/A
NCT06227065 Precise Neoadjuvant Chemoresection of Low Grade NMIBC Status NOT_YET_RECRUITING Phase PHASE2
NCT06187506 Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE2
NCT06126796 Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC) Status COMPLETED Phase N/A
NCT05996952 RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer Status NOT_YET_RECRUITING Phase PHASE2